These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 3311265)

  • 1. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets.
    Radomski MW; Palmer RM; Moncada S
    Br J Pharmacol; 1987 Sep; 92(1):181-7. PubMed ID: 3311265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide.
    Radomski MW; Palmer RM; Moncada S
    Br J Pharmacol; 1987 Nov; 92(3):639-46. PubMed ID: 3322462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic inhibition of platelet aggregation by endothelium-derived relaxing factor and prostacyclin.
    Macdonald PS; Read MA; Dusting GJ
    Thromb Res; 1988 Mar; 49(5):437-49. PubMed ID: 3287674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelium-derived relaxing factor inhibits in vitro platelet aggregation.
    Furlong B; Henderson AH; Lewis MJ; Smith JA
    Br J Pharmacol; 1987 Apr; 90(4):687-92. PubMed ID: 3495310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superoxide dismutase cooperates with prostacyclin to inhibit platelet aggregation: a comparative study in washed platelets and platelet rich plasma.
    Salvemini D; de Nucci G; Vane JR
    Thromb Haemost; 1991 Apr; 65(4):421-4. PubMed ID: 1647553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
    Krishnamurthi S; Westwick J; Kakkar VV
    Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase.
    Wu CC; Ko FN; Kuo SC; Lee FY; Teng CM
    Br J Pharmacol; 1995 Oct; 116(3):1973-8. PubMed ID: 8640334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human endothelial cells inhibit platelet aggregation by separately stimulating platelet cyclic AMP and cyclic GMP.
    Alheid U; Reichwehr I; Förstermann U
    Eur J Pharmacol; 1989 May; 164(1):103-10. PubMed ID: 2546782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelium-derived relaxing factor (EDRF): a defence mechanism against platelet aggregation and vasospasm in human coronary arteries.
    Förstermann U; Mügge A; Alheid U; Bode SM; Frölich JC
    Eur Heart J; 1989 Nov; 10 Suppl F():36-43. PubMed ID: 2620689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet inhibition by endothelium-derived relaxing factor from the rabbit perfused aorta.
    Bult H; Fret HR; Van den Bossche RM; Herman AG
    Br J Pharmacol; 1988 Dec; 95(4):1308-14. PubMed ID: 3064856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of guanylate cyclase and inhibition of platelet aggregation by endothelium-derived relaxing factor released from cultured cells.
    Hawkins DJ; Meyrick BO; Murray JJ
    Biochim Biophys Acta; 1988 May; 969(3):289-96. PubMed ID: 2897209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dipyridamole potentiates the anti-aggregating and vasodilator activity of nitric oxide.
    Bult H; Fret HR; Jordaens FH; Herman AG
    Eur J Pharmacol; 1991 Jun; 199(1):1-8. PubMed ID: 1909961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelium-derived relaxant factor inhibits platelet activation.
    Busse R; Lückhoff A; Bassenge E
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Nov; 336(5):566-71. PubMed ID: 2830546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelium-derived relaxing factor from cultured human endothelial cells inhibits aggregation of human platelets.
    Alheid U; Frölich JC; Förstermann U
    Thromb Res; 1987 Sep; 47(5):561-71. PubMed ID: 3499684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic effects of peroxynitrite: inhibition and reversal of aggregation in human platelets.
    Yin K; Lai PS; Rodriguez A; Spur BW; Wong PY
    Prostaglandins; 1995 Sep; 50(3):169-78. PubMed ID: 8750213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human endothelial cells maintain anti-aggregatory activity for platelets during apoptosis.
    Xu W; Favaloro EJ; Medbury H; Zoellner H
    Thromb Haemost; 2001 May; 85(5):915-23. PubMed ID: 11372688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of platelet-derived mitogen release by nitric oxide (EDRF).
    Barrett ML; Willis AL; Vane JR
    Agents Actions; 1989 Jun; 27(3-4):488-91. PubMed ID: 2508448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioassay of prostacyclin and endothelium-derived relaxing factor (EDRF) from porcine aortic endothelial cells.
    Gryglewski RJ; Moncada S; Palmer RM
    Br J Pharmacol; 1986 Apr; 87(4):685-94. PubMed ID: 3085757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of hericenone B from Hericium erinaceus on collagen-induced platelet aggregation.
    Mori K; Kikuchi H; Obara Y; Iwashita M; Azumi Y; Kinugasa S; Inatomi S; Oshima Y; Nakahata N
    Phytomedicine; 2010 Dec; 17(14):1082-5. PubMed ID: 20637576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of bovine endothelial thromboxane receptors triggers release of prostacyclin but not EDRF.
    Clesham G; Parsaee H; Joseph S; McEwan JR; MacDermot J
    Cardiovasc Res; 1992 May; 26(5):513-7. PubMed ID: 1446322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.